Table 2 |
|||
|
Incidental findings from MRI scanning |
|||
|
Finding |
Number |
Percentage |
Management |
|
|
|||
|
WML |
54 |
27% |
NFA |
|
|
|||
|
WML + cerebral atrophy |
6 |
3% |
NFA |
|
|
|||
|
Sinus findings |
5 |
2.5% |
NFA |
|
|
|||
|
Vascular infarcts |
4 |
2% |
NFA |
|
|
|||
|
WML + sinus findings |
4 |
2% |
NFA |
|
|
|||
|
Cerebral atrophy |
3 |
1.5% |
NFA |
|
|
|||
|
Middle ear/mastoid findings |
3 |
1.5% |
NFA |
|
|
|||
|
Glioma |
2 |
1% |
NSR |
|
|
|||
|
Extensive WML |
2 |
1% |
NLR |
|
|
|||
|
Arachnoid cyst |
2 |
1% |
NFA |
|
|
|||
|
WML + middle ear/mastoid findings |
2 |
1% |
NFA |
|
|
|||
|
Cerebral atrophy + sinus findings |
2 |
1% |
NFA |
|
|
|||
|
Vascular anomaly |
2 |
1% |
NFA |
|
|
|||
|
Lipoma |
1 |
0.5% |
NSR |
|
|
|||
|
Meningioma |
1 |
0.5% |
NFA |
|
|
|||
|
Sinus findings and Middle ear/mastoid findings |
1 |
0.5% |
NFA |
|
|
|||
|
Enhancement around facial nerve |
1 |
0.5% |
NFA |
|
|
|||
|
(NFA = no further action, NSR = Neurosurgical referral, NLR = Neurology referral) |
|||
|
Papanikolaou et al. BMC Ear, Nose and Throat Disorders 2010 10:6 doi:10.1186/1472-6815-10-6 |
|||